LRRC15 activators encompass a group of chemicals that modulate the activity of the Leucine Rich Repeat Containing 15 (LRRC15) protein, which is known to be expressed in a variety of human tissues and has been implicated in cellular adhesion and migration. LRRC15 is characterized by the presence of leucine-rich repeats, a motif that is typically involved in protein-protein interactions and may confer a range of functional capabilities, including involvement in signaling pathways and extracellular matrix interactions.
Direct activators of LRRC15 may bind to the protein itself, altering its conformation in a way that enhances its natural function, which could include promoting its interaction with other cell surface proteins or ligands within the extracellular matrix. This might result in an upregulation of cellular processes that are dependent on LRRC15, such as the modulation of cell adhesion dynamics or the migration of cells during tissue remodeling. Indirect activators may work by influencing the expression levels of LRRC15, either by upregulating the gene that encodes it, enhancing the stability of its mRNA, or by modulating the proteolytic processing of the protein, thereby increasing its presence on the cell surface. Other indirect mechanisms could involve the inhibition of negative regulators of LRRC15 or the modification of signaling pathways that impact LRRC15 function, thereby promoting its activity.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C which can influence multiple signaling pathways, potentially affecting LRRC15 expression. | ||||||
LY2109761 | 700874-71-1 | sc-396262 sc-396262A | 1 mg 5 mg | $89.00 $275.00 | 9 | |
An inhibitor of TGFβ receptor type I/II, it may indirectly influence LRRC15 by modulating TGF-β pathways. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor; epigenetic changes can modulate gene expressions including potentially LRRC15. | ||||||
IWR-1-endo | 1127442-82-3 | sc-295215 sc-295215A | 5 mg 10 mg | $82.00 $135.00 | 19 | |
A Wnt pathway inhibitor; by influencing the Wnt pathway, it can have downstream effects on related proteins like LRRC15. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
TGF-β type I receptor inhibitor; by modulating TGF-β signaling, it may influence LRRC15 expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, raising cAMP levels, which can influence various pathways and potentially LRRC15 levels. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
Notch pathway inhibitor; modulation of the Notch pathway can have downstream effects on related proteins like LRRC15. | ||||||
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $202.00 $811.00 | 16 | |
TGF-β type I receptor ALK5 inhibitor; again, by influencing TGF-β signaling, LRRC15 might be indirectly impacted. | ||||||